Evidence map›Paper›PMID 36862514›Full record

ArticleJCI insight2023

l-Type amino acid transporter 1 in hypothalamic neurons in mice maintains energy and bone homeostasis.

Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Yusuke Masuo, Yuka Inaba, Takanori Tatsuno, Takanori Yamada, Kazuya Tokumura, Sayuki Iwahashi, Takashi Iezaki and 12 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Brain Nutrient Sensing: A Unifying Framework.Annual review of physiology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Gyujin ParkDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Kazuya FukasawaDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Tetsuhiro HorieDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Yusuke MasuoFaculty of Pharmacy, College of Medical, Pharmaceutical and Health, and.
Yuka InabaMetabolism and Nutrition Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan.
Takanori TatsunoMedical Research Institute, Kanazawa Medical University, Kahoku, Ishikawa, Japan.
Takanori YamadaDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Kazuya TokumuraDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Sayuki IwahashiDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Takashi IezakiDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Katsuyuki KanedaLaboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa, Japan.
Yukio KatoFaculty of Pharmacy, College of Medical, Pharmaceutical and Health, and.
Yasuhito IshigakiMedical Research Institute, Kanazawa Medical University, Kahoku, Ishikawa, Japan.
Michihiro MiedaDepartment of Integrative Neurophysiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Tomohiro TanakaDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Kazuma OgawaLaboratory of Clinical Analytical Sciences, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa, Japan.
Hiroki OchiDepartment of Rehabilitation for Motor Functions, Research Institute, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Saitama, Japan.
Shingo SatoCenter for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo, Japan.
Yun-Bo ShiSection on Molecular Morphogenesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.
Hiroshi InoueMetabolism and Nutrition Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan.
Hojoon LeeDepartment of Neurobiology, Northwestern University, Evanston, Illinois, USA.
Eiichi HinoiDepartment of Bioactive Molecules, Laboratory Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Gifu Pharmaceutical University · JPKanazawa University · JPKanazawa Medical University · JPNorthwestern University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USNagoya City University · JPNational Rehabilitation Center for Persons with Disabilities · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypothalamic neurons regulate body homeostasis by sensing and integrating changes in the levels of key hormones and primary nutrients (amino acids, glucose, and lipids). However, the molecular mechanisms that enable hypothalamic neurons to detect primary nutrients remain elusive. Here, we identified l-type amino acid transporter 1 (LAT1) in hypothalamic leptin receptor-expressing (LepR-expressing) neurons as being important for systemic energy and bone homeostasis. We observed LAT1-dependent amino acid uptake in the hypothalamus, which was compromised in a mouse model of obesity and diabetes. Mice lacking LAT1 (encoded by solute carrier transporter 7a5, Slc7a5) in LepR-expressing neurons exhibited obesity-related phenotypes and higher bone mass. Slc7a5 deficiency caused sympathetic dysfunction and leptin insensitivity in LepR-expressing neurons before obesity onset. Importantly, restoring Slc7a5 expression selectively in LepR-expressing ventromedial hypothalamus neurons rescued energy and bone homeostasis in mice deficient for Slc7a5 in LepR-expressing cells. Mechanistic target of rapamycin complex-1 (mTORC1) was found to be a crucial mediator of LAT1-dependent regulation of energy and bone homeostasis. These results suggest that the LAT1/mTORC1 axis in LepR-expressing neurons controls energy and bone homeostasis by fine-tuning sympathetic outflow, thus providing in vivo evidence of the implications of amino acid sensing by hypothalamic neurons in body homeostasis.

Indexed as

HypothalamusLarge Neutral Amino Acid-Transporter 1AnimalsHomeostasisMechanistic Target of Rapamycin Complex 1MiceNeuronsObesityLarge Neutral Amino Acid-Transporter 1Mechanistic Target of Rapamycin Complex 1Amino acid metabolismBone BiologyBone diseaseEndocrinologyObesity

Identifiers

PMID36862514
PMCPMC10132163
OpenAlexW4322757333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.